Financial Gravity Asset Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6
Closed -$100 2044
2024
Q1
$100 Buy
6
+4
+200% +$60 ﹤0.01% 1739
2023
Q4
$8 Buy
2
+1
+100% +$7 ﹤0.01% 1483
2023
Q3
$3 Sell
1
-4
-80% -$20 ﹤0.01% 1212
2023
Q2
$13 Sell
5
-2
-29% -$12 ﹤0.01% 1520
2023
Q1
$4 Hold
7
﹤0.01% 939
2022
Q4
$17 Buy
7
+4
+133% +$22 ﹤0.01% 1335
2022
Q3
$2 Buy
+3
New +$11 ﹤0.01% 828
2021
Q4
Sell
-1
Closed -$21K 985
2021
Q3
$21K Hold
1
0.01% 798
2021
Q2
$27K Buy
+1
New +$29 0.01% 742
2019
Q4
Sell
-12
Closed 1591
2019
Q3
$0 Buy
+12
New +$173 ﹤0.01% 1419

Other funds holding MGNX

Financial Gravity Asset Management's MGNX Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 6 shares — an estimated $100 sold.

Financial Gravity Asset Management first reported a position in MGNX in Q3 2019 and held it in 10 quarters. The position peaked at $27K in Q2 2021. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 6 MacroGenics shares in Q2 2024, an estimated $100.
  • Financial Gravity Asset Management first reported a position in MacroGenics in Q3 2019 and held it in 10 quarters.
  • Financial Gravity Asset Management's MacroGenics position peaked at $27K in Q2 2021.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.